Lanean...
Oncology Drug Development and Approval of Systemic Anticancer Therapy by the U.S. Food and Drug Administration
BACKGROUND. Regulatory approval of oncology drugs is the cornerstone of the development process and approval characteristics shape eventual utilization. Approval trends and characteristics provide valuable information for drug developers and regulators and ultimately affect clinicians and patients....
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AlphaMed Press
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556246/ https://ncbi.nlm.nih.gov/pubmed/23263289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0235 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|